Recombinant Human E2F1, MYC/DDK-tagged

• Cat.No.: E2F1-238H
• Product Overview: Recombinant Human E2F1 fussed with MYC/DDK tag at C-terminal was expressed in HEK293 cells.

Specification

• Description: The protein encoded by this gene is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F proteins contain several evolutionally conserved domains found in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. This protein and another 2 members, E2F2 and E2F3, have an additional cyclin binding domain. This protein binds preferentially to retinoblastoma protein pRB in a cell-cycle dependent manner. It can mediate both cell proliferation and p53-dependent/independent apoptosis.
• Source: HEK293 cells
• Species: Human
• Tag: Myc&DDK
• Form: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol.
• Molecular Mass: 46.7 kDa
• Purity: >80% as determined by SDS-PAGE and Coomassie blue staining
• Concentration: >50 ug/mL as determined by microplate BCA method

Gene Information

• Gene Name: E2F1 E2F transcription factor 1 [ Homo sapiens ]
• Official Symbol: E2F1
• Synonyms: RBP3; E2F-1; RBAP1; RBBP3; transcription factor E2F1; PBR3; PRB-binding protein E2F-1; RBAP-1; RBBP-3; retinoblastoma-associated protein 1; retinoblastoma-binding protein 3
• Gene ID: 1869
• mRNA Refseq: NM_005225
• Protein Refseq: NP_005216
• MIM: 189971
• UniProt ID: Q01094
• Chromosome Location: 20q11.2
• Pathway: Activation of BH3-only proteins, organism-specific biosystem; Activation of PUMA and translocation to mitochondria, organism-specific biosystem; Apoptosis, organism-specific biosystem
• Function: DNA binding; core promoter binding; sequence-specific DNA binding

Reviews

06/20/2022

The versatility of the E2F1 protein is truly remarkable, as it can be employed across a wide range of applications in my research.

01/16/2022

In addition to its outstanding quality, the manufacturer of the E2F1 protein offers excellent technical support that can effectively address any challenges I may encounter.

03/23/2016

Their dedicated team of experts is readily available to provide guidance and assistance, ensuring a seamless integration of the E2F1 protein into my experimental setup.

Q&As

Can E2F1 be used in prognostic assessments for cancer patients?

E2F1 expression patterns may serve as prognostic indicators, helping predict the likelihood of disease progression and informing treatment strategies.

How does E2F1 contribute to drug resistance in cancer?

E2F1 overexpression has been linked to drug resistance in cancer cells, presenting a challenge in chemotherapy and necessitating further research for effective solutions.

What other diseases or conditions are associated with E2F1 dysfunction?

E2F1 dysregulation has been implicated in various diseases beyond cancer, including neurodegenerative disorders and cardiovascular diseases.

Are there any clinical trials targeting E2F1 for therapeutic interventions?

Clinical trials are investigating the potential of targeting E2F1 in cancer treatment, exploring novel drugs and treatment approaches.

How does E2F1 interact with other proteins in cellular processes?

E2F1 interacts with several proteins to form complexes that regulate gene expression, influencing cellular processes such as DNA replication and repair.